Search

Your search keyword '"V, Pengo"' showing total 38 results

Search Constraints

Start Over You searched for: Author "V, Pengo" Remove constraint Author: "V, Pengo" Language undetermined Remove constraint Language: undetermined
38 results on '"V, Pengo"'

Search Results

1. Frailty and outcomes in octogenarians with atrial fibrillation treated with edoxaban: ESCAPE study

2. POS0462 HYDROXYCHLOROQUINE REDUCES THE TITERS OF ANTI-DOMAIN 1 ANTIBODIES OVER TIME IN PATIENTS WITH PERSISTENTLY POSITIVE ANTIPHOSPHOLIPID ANTIBODIES: RESULTS FROM THE APS ACTION CLINICAL DATABASE AND REPOSITORY ('REGISTRY')

3. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

4. P4671A well-defined subgroup of chronic thromboembolic pulmonary hypertension patients are positive for antiphospholipid antibodies

5. Oral and Poster Presentations

6. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

7. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis

8. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study

9. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation

10. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study

11. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up

13. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

14. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants

15. [Thromboembolism in non-rheumatic atrial fibrillation]

16. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update]

17. Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment)

18. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK)

20. The management of oral anticoagulant therapy: the patient's point of view

21. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity

22. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies

23. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation

24. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy)

25. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids

26. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

27. [Primary pulmonary hypertension and anticoagulant therapy]

28. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface

29. Immunological specificity and mechanism of action of IgG lupus anticoagulants

31. [Thrombolytic therapy with urokinase in 8 patients with massive pulmonary thromboembolism]

33. [Study of blood platelet activation in migraine in childhood]

37. Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer

Catalog

Books, media, physical & digital resources